Switching from sleeping pills to daridorexant for insomnia
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether switching from common sleeping pills (BZRAs) to a newer medicine called daridorexant helps people with insomnia sleep better and feel better during the day. It is for adults who are not fully satisfied with their current sleeping pill or have side effects from it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have had trouble sleeping (falling asleep, staying asleep, or waking too early) at least 3 nights a week for 3 months or more.
- You have been taking one sleeping pill (a BZRA) at least 3 nights a week for the past month.
- You spend at least 7 hours in bed each night.
- You are not happy with your current sleeping pill or it causes side effects, and your doctor agrees you need a change.
- You do not have severe depression, anxiety, or other major mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new sleep medication called daridorexant for people with liver cirrhosis who also have trouble sleeping. The study aims to see if the drug improves sleep quality and is safe for this group.
This study follows adults with insomnia who are prescribed a new sleep medication called daridorexant. It aims to see how well the medication works in a real-world setting, and to monitor its safety and effects on sleep.
This trial tests a new medicine, daridorexant, to see if it helps people with insomnia sleep better through the night and feel more alert during the day. The study will use a home device to check your sleep patterns before you join.
This study tests an experimental sleep aid called daridorexant for people who have both depression and insomnia. It aims to see if the drug can improve sleep without worsening depression symptoms.
This trial tests whether daridorexant can improve sleep in people who have mild cognitive impairment or early Alzheimer’s disease and struggle with insomnia. It may help by improving how long and how well you sleep, with monitoring of sleep patterns and memory-related measures.
This study tests a sleep medication called daridorexant to see if it helps people with both insomnia and alcohol use disorder sleep better and reduce drinking. It may offer a new way to address both problems together.
Hear when a new Insomnia Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.